Stonegate Investment Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.24M Buy
11,472
+15
+0.1% +$4.35K 0.08% 105
2025
Q2
$3.2M Sell
11,457
-1,823
-14% -$516K 0.08% 100
2025
Q1
$4.14M Sell
13,280
-520
-4% -$154K 0.11% 76
2024
Q4
$3.6M Sell
13,800
-244,847
-95% -$72.6M 0.1% 83
2024
Q3
$83.3M Buy
258,647
+3,217
+1% +$1.05M 2.19% 14
2024
Q2
$79.8M Buy
255,430
+116,992
+85% +$34.4M 2.31% 12
2024
Q1
$39.4M Buy
138,438
+127,475
+1,163% +$37.3M 1.23% 31
2023
Q4
$3.16M Sell
10,963
-467
-4% -$127K 0.1% 85
2023
Q3
$3.07M Buy
11,430
+6
+0.1% +$1.5K 0.11% 83
2023
Q2
$2.54M Buy
11,424
+13
+0.1% +$3.02K 0.09% 92
2023
Q1
$2.76M Buy
11,411
+1,405
+14% +$345K 0.1% 92
2022
Q4
$2.63M Buy
10,006
+6,674
+200% +$1.79M 0.11% 87
2022
Q3
$751K Buy
3,332
+123
+4% +$29.8K 0.03% 148
2022
Q2
$781K Buy
+3,209
New +$786K 0.03% 150

Other funds holding AMGN

Stonegate Investment Group's AMGN Position: Q3 2025 in Review

Stonegate Investment Group increased its Amgen (AMGN) stake by 0.13% in Q3 2025, buying an estimated $4.35K and bringing the position to 11,472 shares worth $3.24M. The position accounts for 0.08% of the portfolio, ranked #105.

Stonegate Investment Group first reported a position in AMGN in Q2 2022 and has held it in 14 quarters since. The position peaked at $83.3M in Q3 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Stonegate Investment Group held 11,472 shares of Amgen worth $3.24M as of Q3 2025.
  • Stonegate Investment Group bought 15 Amgen shares in Q3 2025, an estimated $4.35K.
  • Amgen made up 0.08% of Stonegate Investment Group's portfolio in Q3 2025, its #105 holding.
  • Stonegate Investment Group first reported a position in Amgen in Q2 2022 and has held it in 14 quarters since.
  • Stonegate Investment Group's Amgen position peaked at $83.3M in Q3 2024.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.